Statistics from Altmetric.com
We read the article ‘'N-terminal pro-brain-type natriuretic peptide (NT-pro-BNP) and mortality risk in early inflammatory polyarthritis (IP): results from the Norfolk Arthritis Registry (NOAR)’’ by Mirjafari et al1 with interest. The authors aimed to measure serum NT-pro-BNP levels in a large, well-characterised inception cohort of patients with early IP and examine baseline association of NT-pro-BNP levels with IP disease phenotype, clinical cardiovascular disease (CVD) risk markers and subclinical atherosclerosis surrogates. They concluded that in early IP patients, elevated NT-pro-BNP is related to Health Assessment Questionnaire …
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.